Skip to main content
. Author manuscript; available in PMC: 2008 Jul 1.
Published in final edited form as: Neuropsychopharmacology. 2007 Apr 18;33(2):219–225. doi: 10.1038/sj.npp.1301420

Table 1.

Self-administration histories (mg/kg) prior to [11C]DASB PET studies

1Weekly
MDMA Intake
Total
MDMA Intake
2Months of SA (−) Cocaine
MDMA Group
R-1361 22.2 107.46 6 118.33
R-1496 6.2 138.44 18 69.75
R-1498 6.8 96.63 8 80.01
R-1499 3.9 141.74 16 0.2
Mean (± SEM) 121.07 (13.0) 12 (3.4) 67.07 (28.4)
1Weekly
Cocaine Intake
Total
Cocaine Intake
2Months of SA (±) MDMA
Cocaine Group
R-1268 1.8 1028.79 10 0.00
R-1326 1.83 537.27 12 129.55
R-1346 24 645.3 5 40.61
R-1427 2.19 759.04 14 0.00
Mean (± SEM) 742.60 (121.9) 10.25 (2.2) 42.54 (35.3)
1

Weekly Intake (mg/kg) refers to drug intake over the 5 days before the PET study.

2

“Months of SA” refers to the number of months each subject had been exclusively self-administering either MDMA or cocaine.

HHS Vulnerability Disclosure